These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Financial tombstone celebrating the spin-off of San Diego-based CareFusion to Cardinal Health, a drug development corporation headquartered in Dublin, Ohio. Joint financial advisers to Cardinal Health included Bank of America Merrill Lynch and J.P. Morgan.
Custom lucite dealtoy related to the acquisition of scientific supplies distributor VWR, based in West Chester, Pennsylvania, to Clayton, Dubilier & Rice, a New York-based private equity firm.
Lucite deal toys related to notes issued by Nashville-based hospital operator Vanguard Health Systems
Lab flask-themed custom Lucite recognizing the restructuring of Almatis, based in Frankfurt, Germany. Moelis & Company of New York City served as the company’s exclusive U.S. financial advisor.
Lucite tombstone marking the acquisition of Minneapolis-based Airborne, Inc. by Schiff Nutrition of Salt Lake City. Airborne was advised by New York investment banking firm Sawaya Segalas.
Custom Lucite recognizing Swedish-based pharmaceutical firm Meda’s acquisition of several consumer brands from GlaxoSmithKline, headquartered in Brentford, England. GlaxoSmithKline was advised in the transaction by Sawaya Segalas, a firm based in New York City.
Lucite dealtoy marking the acquisition of Boca Raton-based MDVIP, a doctors network, by Procter & Gamble. Procter & Gamble is headquartered in Cincinnati, Ohio.
Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
"*" indicates required fields
